Iterum Therapeutics plc (ITRMF) Return on Sales (2017 - 2025)
Iterum Therapeutics (ITRMF) posted quarterly Return on Sales of 0.23% for Q3 2025, up 99.17% quarter-over-quarter from 27.87% in Q4 2019.
Iterum Therapeutics plc (ITRMF) Return on Sales (2017 - 2025) Analysis & Trends
Iterum Therapeutics' Return on Sales history runs 4 years deep, the most recent figure standing at 0.23% for Q3 2025.
- In Q3 2025, Return on Sales changed N/A year-over-year to 0.23%; the TTM figure through Sep 2025 stood at 0.03% (changed N/A YoY), while the FY2019 annual figure was 27.87%, down 2699.0% from the prior year.
- Return on Sales for Q3 2025 stood at 0.23%, up from 27.87% in the prior quarter.
- The five-year high for Return on Sales was 0.23% in Q3 2025, with the low at 0.23% in Q3 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -0.23% |
| Dec 31, 2019 | -27.87% |
| Sep 30, 2019 | -3.76% |
| Jun 30, 2019 | -1.84% |
| Mar 31, 2019 | -5.56% |
| Dec 31, 2018 | -1.01% |
| Sep 30, 2018 | -0.98% |
| Jun 30, 2018 | -0.85% |
| Mar 31, 2018 | -0.64% |
| Dec 31, 2017 | -0.25% |
| Sep 30, 2017 | -0.51% |